Ignite Creation Date:
2025-12-24 @ 1:52 PM
Ignite Modification Date:
2026-02-20 @ 2:32 PM
Study NCT ID:
NCT05837195
Status:
UNKNOWN
Last Update Posted:
2023-05-01
First Post:
2023-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Diastolic Deceleration Area in Late-onset FGR
Sponsor:
Orthogyn Medical Center, Bulgaria
Organization:
Study Overview
Official Title:
Diastolic Deceleration Area (DDA) in Late-onset Fetal Growth Restriction (FGR)
Status:
UNKNOWN
Status Verified Date:
2023-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
DDA is a new Doppler parameter aiming to assess fetal well-being in-utero. Late-onset FGR is a specific subgroup of fetuses where the clinical application of this Doppler modality could play an essential role in detecting hypoxia, anemia, and other adverse neonatal outcomes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: